Here’s what it really takes to score $1,000 a month in dividends. Read More

Hardware complete with software to govern it could make a sales pitch to an automaker a whole lot easier. Read More

The electric-car maker’s blazing growth continued during the period. Here’s a closer look at the important takeaways from the quarter. Read More

Will strong Q4 estimates push the stock price to new levels? Read More

Craft growers shouldn’t be overlooked. Read More

These stocks have characteristics that make it easier to ignore short-term volatility. Read More

Zoom was already building its own contact center solution even prior to the Five9 deal getting shot down. Read More

The insurance disruptor is down big from its highs, but one of our experts is adding shares. Read More

One Motley Fool contributor is looking forward to the quarterly updates from these healthcare stocks. Read More

Eli Lilly and Incyte’s Olumiant could be a groundbreaking therapy for patients with alopecia areata. Read More